CDK6 and cancer: In conclusion, we deem that CDK6-PI3K axis can be ideal target for reversing ABCB1 mediated MDR in cancers without inducing cancer cell proliferation, and this finding is of great significance for the combined anticancer chemotherapy which can reverse multidrug resistance and inhibit the growth of tumor cells at the same time.